FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4353094265> ?p ?o ?g. }

• W4353094265 endingPage "383" @default.
• W4353094265 startingPage "376" @default.
• W4353094265 abstract "•Familial hypercholesterolemia (FH) is associated with a lifelong elevation in LDL-C. •Atherosclerotic cardiovascular disease (ASCVD) risk in FH is high but heterogeneous. •The prevalence of metabolic syndrome (MetS) in a multinational cohort of FH was 14%. •The presence of MetS was associated with a 2-fold increased risk of incident ASCVD. •The presence of MetS was associated with a 4.9-fold increased risk of mortality. Background The association between familial hypercholesterolemia (FH) and premature atherosclerotic cardiovascular disease (ASCVD) is well established. Several risk factors other than the cumulative low-density lipoprotein cholesterol (LDL-C) have been shown to modulate the severity of the phenotype in these patients. However, the effect of the metabolic syndrome (MetS) on ASCVD risk in FH remains to be determined. Objectives The objective was to study the association between the presence of MetS and the incidence of different ASCVD endpoints and all-cause mortality. Methods This prospective follow up study used data from 5 independent FH cohorts from Europe and North America. We analysed data of 2401 adult heterozygous FH without history of a prior ASCVD event (21,139 person-years of follow-up). Multivariate Cox proportional hazards regression was used to estimate the association between MetS and the incidence of the different endpoints. Results The prevalence of MetS was 14% in the study population. The presence of MetS was a significant predictor of incident 10-year ASCVD after adjustment for traditional cardiovascular risk factors (HR 2.07, 95% CI 1.34-3.19), as well as of 10-year major adverse cardiovascular event (MACE) (HR 4.59, 95% CI 2.27-9.30), 10-year myocardial infarction (MI) (HR 4.29, 95% CI 1.91-9.63), and 30-year all-cause mortality (HR 4.87, 95% CI 1.99-11.89). Conclusion Our findings suggests that FH patients with MetS, have an increased cardiovascular risk that is independent from LDL-C and other traditional risk factors. Future studies are required to determine the most appropriate strategy to reduce the cardiovascular burden associated with MetS in this population. The association between familial hypercholesterolemia (FH) and premature atherosclerotic cardiovascular disease (ASCVD) is well established. Several risk factors other than the cumulative low-density lipoprotein cholesterol (LDL-C) have been shown to modulate the severity of the phenotype in these patients. However, the effect of the metabolic syndrome (MetS) on ASCVD risk in FH remains to be determined. The objective was to study the association between the presence of MetS and the incidence of different ASCVD endpoints and all-cause mortality. This prospective follow up study used data from 5 independent FH cohorts from Europe and North America. We analysed data of 2401 adult heterozygous FH without history of a prior ASCVD event (21,139 person-years of follow-up). Multivariate Cox proportional hazards regression was used to estimate the association between MetS and the incidence of the different endpoints. The prevalence of MetS was 14% in the study population. The presence of MetS was a significant predictor of incident 10-year ASCVD after adjustment for traditional cardiovascular risk factors (HR 2.07, 95% CI 1.34-3.19), as well as of 10-year major adverse cardiovascular event (MACE) (HR 4.59, 95% CI 2.27-9.30), 10-year myocardial infarction (MI) (HR 4.29, 95% CI 1.91-9.63), and 30-year all-cause mortality (HR 4.87, 95% CI 1.99-11.89). Our findings suggests that FH patients with MetS, have an increased cardiovascular risk that is independent from LDL-C and other traditional risk factors. Future studies are required to determine the most appropriate strategy to reduce the cardiovascular burden associated with MetS in this population." @default.
• W4353094265 created "2023-03-23" @default.
• W4353094265 creator A5004521406 @default.
• W4353094265 creator A5012038189 @default.
• W4353094265 creator A5015391503 @default.
• W4353094265 creator A5022102417 @default.
• W4353094265 creator A5025768417 @default.
• W4353094265 creator A5027540498 @default.
• W4353094265 creator A5029200964 @default.
• W4353094265 creator A5059449703 @default.
• W4353094265 creator A5067391389 @default.
• W4353094265 date "2023-05-01" @default.
• W4353094265 modified "2023-10-03" @default.
• W4353094265 title "Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia" @default.
• W4353094265 cites W1990563195 @default.
• W4353094265 cites W2033195676 @default.
• W4353094265 cites W2049134985 @default.
• W4353094265 cites W2051712081 @default.
• W4353094265 cites W2052083732 @default.
• W4353094265 cites W2108587366 @default.
• W4353094265 cites W2129448542 @default.
• W4353094265 cites W2134293572 @default.
• W4353094265 cites W2143104968 @default.
• W4353094265 cites W2154704322 @default.
• W4353094265 cites W2165624352 @default.
• W4353094265 cites W2492051419 @default.
• W4353094265 cites W2505204533 @default.
• W4353094265 cites W2563256359 @default.
• W4353094265 cites W2567297878 @default.
• W4353094265 cites W2765610051 @default.
• W4353094265 cites W2793323219 @default.
• W4353094265 cites W2890833213 @default.
• W4353094265 cites W2902955133 @default.
• W4353094265 cites W2979827518 @default.
• W4353094265 cites W2980876689 @default.
• W4353094265 cites W3024375461 @default.
• W4353094265 cites W3028800184 @default.
• W4353094265 cites W3039340826 @default.
• W4353094265 cites W3125503134 @default.
• W4353094265 cites W3173695887 @default.
• W4353094265 cites W3194362009 @default.
• W4353094265 cites W3196184830 @default.
• W4353094265 cites W4210956151 @default.
• W4353094265 cites W4221062056 @default.
• W4353094265 cites W4225733914 @default.
• W4353094265 cites W4280548962 @default.
• W4353094265 doi "https://doi.org/10.1016/j.jacl.2023.03.008" @default.
• W4353094265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37003850" @default.
• W4353094265 hasPublicationYear "2023" @default.
• W4353094265 type Work @default.
• W4353094265 citedByCount "1" @default.
• W4353094265 crossrefType "journal-article" @default.
• W4353094265 hasAuthorship W4353094265A5004521406 @default.
• W4353094265 hasAuthorship W4353094265A5012038189 @default.
• W4353094265 hasAuthorship W4353094265A5015391503 @default.
• W4353094265 hasAuthorship W4353094265A5022102417 @default.
• W4353094265 hasAuthorship W4353094265A5025768417 @default.
• W4353094265 hasAuthorship W4353094265A5027540498 @default.
• W4353094265 hasAuthorship W4353094265A5029200964 @default.
• W4353094265 hasAuthorship W4353094265A5059449703 @default.
• W4353094265 hasAuthorship W4353094265A5067391389 @default.
• W4353094265 hasConcept C120665830 @default.
• W4353094265 hasConcept C121332964 @default.
• W4353094265 hasConcept C126322002 @default.
• W4353094265 hasConcept C188816634 @default.
• W4353094265 hasConcept C2778163477 @default.
• W4353094265 hasConcept C2779120738 @default.
• W4353094265 hasConcept C2779134260 @default.
• W4353094265 hasConcept C2780578515 @default.
• W4353094265 hasConcept C2908647359 @default.
• W4353094265 hasConcept C2909478654 @default.
• W4353094265 hasConcept C50382708 @default.
• W4353094265 hasConcept C511355011 @default.
• W4353094265 hasConcept C61511704 @default.
• W4353094265 hasConcept C71924100 @default.
• W4353094265 hasConcept C72563966 @default.
• W4353094265 hasConcept C88879693 @default.
• W4353094265 hasConcept C99454951 @default.
• W4353094265 hasConceptScore W4353094265C120665830 @default.
• W4353094265 hasConceptScore W4353094265C121332964 @default.
• W4353094265 hasConceptScore W4353094265C126322002 @default.
• W4353094265 hasConceptScore W4353094265C188816634 @default.
• W4353094265 hasConceptScore W4353094265C2778163477 @default.
• W4353094265 hasConceptScore W4353094265C2779120738 @default.
• W4353094265 hasConceptScore W4353094265C2779134260 @default.
• W4353094265 hasConceptScore W4353094265C2780578515 @default.
• W4353094265 hasConceptScore W4353094265C2908647359 @default.
• W4353094265 hasConceptScore W4353094265C2909478654 @default.
• W4353094265 hasConceptScore W4353094265C50382708 @default.
• W4353094265 hasConceptScore W4353094265C511355011 @default.
• W4353094265 hasConceptScore W4353094265C61511704 @default.
• W4353094265 hasConceptScore W4353094265C71924100 @default.
• W4353094265 hasConceptScore W4353094265C72563966 @default.
• W4353094265 hasConceptScore W4353094265C88879693 @default.
• W4353094265 hasConceptScore W4353094265C99454951 @default.
• W4353094265 hasFunder F4320323174 @default.
• W4353094265 hasIssue "3" @default.
• W4353094265 hasLocation W43530942651 @default.

• next